Complete PSA remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection

Advances in Urology

Volumn , Issue , 2012, Pages

  Winter, Alexander ^a   Uphoff, Jens ^a   Henke, Rolf Peter ^b   Wawroschek, Friedhelm ^a  

^a KLINIKUM OLDENBURG   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052651836     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2012/609612     Document Type: Article

References (26)

1. Daneshmand S., Quek M. L., Stein J. P., Lieskovsky G., Cai J., Pinski J., Skinner E. C., Skinner D. G., Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results Journal of Urology 2004 172 6, part 1 2252 2255 (Pubitemid 39507502)
2. von Bodman C., Godoy G., Chade D. C., Cronin A., Tafe L. J., Fine S. W., Laudone V., Scardino P. T., Eastham J. A., Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy Journal of Urology 2010 184 1 143 148
3. Winter A., Uphoff J., Henke R. P., Wawroschek F., First results of PET/CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy Aktuelle Urologie 2009 40 5 294 299
4. Winter A., Uphoff J., Henke R. P., Wawroschek F., First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy Urologia Internationalis 2010 84 4 418 423
5. Scattoni V., Picchio M., Suardi N., Messa C., Freschi M., Roscigno M., Da Pozzo L., Bocciardi A., Rigatti P., Fazio F., Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy European Urology 2007 52 2 423 429 (Pubitemid 46963456)
6. Schilling D., Schlemmer H. P., Wagner P. H., Bttcher P., Merseburger A. S., Aschoff P., Bares R., Pfannenberg C., Ganswindt U., Corvin S., Stenzl A., Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer British Journal of Urology International 2008 102 4 446 451 (Pubitemid 352032836)
7. Rinnab L., Mottaghy F. M., Blumstein N. M., Reske S. N., Hautmann R. E., Hohl K., Mller P., Wiegel T., Kuefer R., Gschwend J. E., Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer British Journal of Urology International 2007 100 4 786 793 (Pubitemid 47360183)
8. Thoeny H. C., Triantafyllou M., Birkhaeuser F. D., Froehlich J. M., Tshering D. W., Binser T., Fleischmann A., Vermathen P., Studer U. E., Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients European Urology 2009 55 4 761 769
9. Bader P., Burkhard F. C., Markwalder R., Studer U. E., Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Journal of Urology 2003 169 3 849 854 (Pubitemid 36188105)
10. Catalona W. J., Miller D. R., Kavoussi L. R., Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy Journal of Urology 1988 140 3 540 543
11. Withrow D. R., Degroot J. M., Siemens D. R., Groome P. A., Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort study. British Journal of Urology International. In press
12. Haas C. J., Wagner T., Wawroschek F., Arnholdt H., Combined application of RT-PCR and immunohistochemistry on paraffin embedded sentinel lymph nodes of prostate cancer patients Pathology Research and Practice 2005 200 1112 763 770 (Pubitemid 40220957)
13. Terakawa T., Miyake H., Kurahashi T., Furukawa J., Takenaka A., Fujisawa M., Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conventional RT-PCR in patients with clinically localized prostate cancer undergoing radical prostatectomy British Journal of Urology International 2009 103 8 1074 1078
14. Hara T., Kosaka N., Kishi H., PET imaging of prostate cancer using carbon-11-choline Journal of Nuclear Medicine 1998 39 6 990 995 (Pubitemid 28270113)
15. Kotzerke J., Volkmer B. G., Glatting G., van den Hoff J., Gschwend J. E., Messer P., Reske S. N., Neumaier B., Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer NuklearMedizin 2003 42 1 25 30 (Pubitemid 36231688)
16. Hcker A., Jeschke S., Leeb K., Prammer K., Ziegerhofer J., Sega W., Langsteger W., Janetschek G., Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection Journal of Urology 2006 176 5 2014 2019 (Pubitemid 44633154)
17. Husarik D. B., Miralbell R., Dubs M., John H., Giger O. T., Gelet A., Cservenyk T., Hany T. F., Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer European Journal of Nuclear Medicine and Molecular Imaging 2008 35 2 253 263
18. de Jong I. J., Pruim J., Elsinga P. H., Vaalburg W., Mensink H. J. A., 11 C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer European Urology 2003 44 1 32 38
19. de Jong I. J., Pruim J., Elsinga P. H., Vaalburg W., Mensink H. J. A., Visualization of prostate cancer with 11C-choline positron emission tomography European Urology 2002 42 1 18 23 (Pubitemid 35345101)
20. Oyama N., Miller T. R., Dehdashti F., Siegel B. A., Fischer K. C., Michalski J. M., Kibel A. S., Andriole G. L., Picus J., Welch M. J., 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse Journal of Nuclear Medicine 2003 44 4 549 555 (Pubitemid 39663421)
21. Hvels A. M., Heesakkers R. A. M., Adang E. M., Jager G. J., Strum S., Hoogeveen Y. L., Severens J. L., Barentsz J. O., The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clinical Radiology 2008 63 4 387 395
22. Beer A. J., Eiber M., Souvatzoglou M., Holzapfel K., Ganter C., Weirich G., Maurer T., Kbler H., Wester H. J., Gaa J., Krause B. J., Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer Molecular Imaging and Biology 2011 13 2 352 361
23. Picchio M., Briganti A., Fanti S., Heidenreich A., Krause B. J., Messa C., Montorsi F., Reske S. N., Thalmann G. N., The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer European Urology 2011 59 1 51 60
24. Vees H., Buchegger F., Albrecht S., Khan H., Husarik D., Zaidi H., Soloviev D., Hany T. F., Miralbell R., 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (1 ng/mL) after radical prostatectomy British Journal of Urology International 2007 99 6 1415 1420 (Pubitemid 47164795)
25. Kanda T., Nakagomi K., Goto S., Torizuka T., Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer Hinyokika Kiyo 2008 54 5 325 332
26. Castellucci P., Fuccio C., Rubello D., Schiavina R., Santi I., Nanni C., Allegri V., Montini G. C., Ambrosini V., Boschi S., Martorana G., Marzola M. C., Fanti S., Is there a role for 11 C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase 1.5 ng/ml? European Journal of Nuclear Medicine and Molecular Imaging 2011 38 1 55 63